Objective: To update and expand The North American Menopause Society’s evidence-based position on nonhormonal management of menopause-associated vasomotor symptoms (VMS), previously a portion of ...

The exact interplay of estrogen and hot flashes isn't entirely understood, but they may be an indicator of your body trying ...

Non-hormonal treatments elinzanetant and fezolinetant effectively manage menopause symptoms, with elinzanetant improving ...

The drop in estrogen can cause uncomfortable symptoms known as vasomotor symptoms, like hot flashes. Your may have other symptoms too, such as vaginal dryness. If you're looking for relief from ...

My primary care physician has been using an AI-assisted device during our office visits that transcribes and records our visits. I receive an after-visit summary a few days later that contains minor ...

Elinzanetant significantly reduced moderate to severe vasomotor symptoms in women on adjuvant endocrine therapy for hormone receptor–positive breast cancer. The OASIS 4 study demonstrated ...

Women’s midlife health is having a long-overdue moment. As social media influencers push perimenopause wonder cures with ...

Elinzanetant successfully met the primary endpoints of the study demonstrating statistically significant reductions in the frequency of moderate to severe vasomotor symptoms (VMS, also known as ...

Elinzanetant reduced vasomotor symptoms frequency and severity in women with or at high risk of HR-positive breast cancer in the OASIS 4 trial.

The purpose of this study was to evaluate the pharmacokinetics of intranasal hydromorphone hydrochloride (HCl) in patients with vasomotor rhinitis. Methods: Ten patients completed the randomised ...